Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    8918275 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
Conditions: Coronary Heart Disease;   Angina Pectoris;   Atherosclerosis
Interventions: Drug: aspirin;   Drug: clopidogrel
2 Completed Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
Conditions: Acute Coronary Syndrome;   Coronary Artery Disease;   Ischemic Stroke;   Peripheral Artery Disease;   Carotid Artery Disease;   Atrial Fibrillation
Intervention:

Indicates status has not been verified in more than two years